SCIB SciBase Holding AB (publ)
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Nevisense.SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.…
Industry Peers
Medical DevicesKey Statistics
About SciBase Holding (STO: SCIB)
›
SciBase Holding (STO: SCIB) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 46 employees.
The shares were at 9.180 SEK on 19 November 2026, down 62.2% over 52 weeks. Its 52-week range is 8.860 SEK to 54.00 SEK: the price is 83.0% below the high and 3.6% above the low.
Its market capitalisation is 129.62M SEK.
SciBase Holding reports an operating margin of -183.1% and revenue up 41.4% year over year.
Its debt exceeds its cash by 8.97M SEK, a debt-to-equity ratio of 3.46. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 29.00 SEK is 215.9% above the current price.